NEW YORK (Reuters Health) - Contrary to preliminary findings, the results of a phase III study failed to show that dextromethorphan significantly enhanced the analgesic effects of morphine in terminally ill patients. The findings are published in the Journal of Pain and Symptom Management.>>> Discuss This Story
